Uthever®: The No.1 NMN Ingredient Brand in the USA

Overview


Effepharm

Uthever® NMN, the flagship ingredient brand under EffePharm, is the world’s first large-scale, human clinically-proven NMN brand. As a precursor to NAD+, NMN plays a crucial role in energy production, DNA repair, and cellular regulation.

Recently, Uthever® has been authoritatively recognized by Euromonitor International as the No.1 trademarked NMN ingredient brand in the USA*.

This “No.1 in U.S. Sales” means that Uthever® helps clients enhance commercial value and provides products backed by professional scientific endorsement.

Download white paper now and get latest information of Uthever® NMN!

This content is paid by Effepharm Ltd, and any views and opinions expressed do not necessarily reflect those of NutraIngredients.com

Download Now


Latest Content

Related Resources

Discover UTHEVER® NMN’s Global Regulatory Landscape

Discover UTHEVER® NMN’s Global Regulatory Landscape

Paid for by Effepharm Ltd

White Paper

NMN has long faced regulatory challenges. Today, that landscape is changing. We consistently invest in scientific research & quality development, aiming to establish UTHEVER® as the world’s most compliant NMN ingredient brand.

The Only & 1st NMN Got Novel Food EFSA Positive Safety Opinion

The Only & 1st NMN Got Novel Food EFSA Positive Safety Opinion

Paid for by Effepharm Ltd

White Paper

On 11th May 2026, EFSA officially published a positive scientific opinion on EffePharm’s β-NMN as a novel food. This is the first-ever EU official safety endorsement for NMN. UTHEVER® is the 1st NMN ingredient brand to receive EFSA’s positive opinion.

Supplier Info Centre

Effepharm-Ltd.jpg

For more product information visit Effepharm Ltd.